-
Mashup Score: 1PBMs using 340B program to drive profits at patients’ expense - 16 day(s) ago
Congress should put an end to the exploitation of this important safety-net program and put it back on track for the patients it was meant to assist.
Source: phrma.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0What We’re Reading: 340B Contract Pharmacies; Nursing Home Ownership; Health Items in Proposed Budget - 1 month(s) ago
An appeals court rules against the Pharmaceutical Research and Manufacturers of America in a 340B contract pharmacy dispute; for-profit investors’ acquisition of nursing homes has raised concerns about the quality of care provided in these facilities; President Joe Biden’s proposed budget for 2025 includes changes that would do away with the current system of biosimilar interchangeability.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4Location, location, location: Hospital markups on biologic meds ‘double’ the costs | BenefitsPRO - 6 month(s) ago
Hospitals are marking up the prices for biologic medicines more than physician offices, particularly for “innovator biologics” that have clinically equivalent (and lower cost alternatives) on the market, says a new report.
Source: www.benefitspro.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3340B Under the Microscope - AAF - 6 month(s) ago
The 340B Drug Pricing Program always seems to find itself in the news, which is handy because the American Action Forum’s health team will never get tired of talking about it. At the end of last week, Ranking Member of the Senate Health, Education, Labor, and Pensions Committee Senator Bill Cassidy (R-LA) announced an investigation into hospital revenue generated by […]
Source: www.americanactionforum.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Agenda - LIVE DAY 1 ✦ September 18 | Medicaid Drug Rebate Program (MDRP) Summit 2023 - 7 month(s) ago
LIVE DAY 1 ✦ September 18. Agenda for day 1 of Medicaid Drug Rebate Program (MDRP) Summit 2023
Source: informaconnect.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Not-for-profit CommonSpirit Health paid its CEO $35 million in 2021 - 8 month(s) ago
Not-for-profit CommonSpirit Health paid its former CEO, Lloyd Dean, $35.5 million in 2021. That’s more than twice what the CEO of similarly sized Ascension made that year.
Source: www.statnews.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1The 340B Program and CommonSpirit Health: The Impact on our Vulnerable Populations | CommonSpirit Health - 8 month(s) ago
CommonSpirit Health has appointed Lilicia Bailey, Ph.D as Senior Executive Vice President and Chief People Officer, effective August 7, 2023. Bailey will serve as a member of the organization’s Executive Leadership Team. CommonSpirit Health’s commitment to sustainability is featured in this Wall Street Journal article about the environmental benefits of virtual care. Dignity Health Global Education and CommonSpirit Health join forces to create a social work fellowship program designed to alleviate
Source: www.commonspirit.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Docs Still Shifting Away From Private Practice, Survey Finds - 8 month(s) ago
Trend is ’emblematic of the fiscal uncertainty and economic stress,’ AMA president says
Source: www.medpagetoday.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 8Biggest 340B benefactors provide relatively less uncompensated care - 9 month(s) ago
Hospitals receiving at least $50 million in proposed remedy payments dedicated an estimated 1.33% of their operating costs to uncompensated care, a Modern Healthcare analysis found.
Source: www.modernhealthcare.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 62340B Analysis Wrong and Irresponsible | AHA News - 9 month(s) ago
Modern Healthcare’s putative report on CMS’ 340B remedy proposal is completely wrong and irresponsible for the following reasons. First, to buttress its conclusions the article relies on quotes from an academic whose 340B research is funded in whole or in part by an organization with an anti-hospital agenda.
Source: www.aha.orgCategories: Hem/Oncs, Latest HeadlinesTweet
RT @oncologyCOA: PBMs using #340B program to drive profits at patients’ expense - from @phrma https://t.co/VFiGIAGK0b